CEO since 27/08/2018

Steen has a bachelor degree in Electronics Engineering from Copenhagen’s Teknikum, and an MBA from London Business School. Throughout his 30-year career, both abroad and in Denmark, he has held positions at Star, Nokia Denmark A/S, Microsoft Inc., Symbian PLC, Psion Software PLC, CompuServe Inc. and TDC. He was also the Managing Director of Specialisterne Foundation, owner of the social economic enterprise, Specialisterne, where he led the establishment and growth of Specialisterne in 15 countries.

Steen Thygesen privately owns 112,790 shares in Audientes A/S.  He also privately holds 670,000 warrants in Audientes A/S.

Founder of Audientes in 2014 and CTO since 27/08/2018

Hossein has an MA in Electric Engineering from Danmark’s Tekniske University. He began his career in Nokia in 1997 as a software engineer and held a number of roles, including Test Manager. In 2012, he founded the hearing aid research and development company, Jelveh Medical Device. In 2014, he founded Audientes.

Hossein Jelved owns 2,255,010 shares in Audientes A/S through the fully controlled holding company Jelveh Holding ApS. He also privately holds 270,000 warrants in Audientes A/S.

Board Chairperson since 03/06/2020

Independent of Company

Povl-André has a Masters of Science from CBS, and a long career in the life sciences industry, where he held several commercial and financial leadership positions. He holds a number of board positions, including Chairman of the Board for 2cureX AB, which is listed on the Nasdaq First North Sweden exchange.

Povl-André Bendz privately owns 26,012 shares in Audientes A/S. He also privately holds 70,000 warrants in Audientes A/S.

Board member since 03/06/2020

Independent of Company

Gitte has a degree in market economies and has more than 20 years of leadership experience within life sciences industries and has worked with strategic and commercial business development. She has held positions that include CFO, COO as well as Supply Chain Manager in pharmaceutical companies, Meda and Mylan. In connection with these, she has participated in several international M&A transactions. She currently holds the CEO position at UV Clinical.

Gitte Jürgens privately owns 2,777 shares in Audientes A/S. She also privately holds  35,000 warrants in Audientes A/S.

Board member since 03/06/2020

Independent of Company

Elsebeth has a university degree in Economics and has held numerous international positions within the life sciences industry, including international manager in GN Danavox A/S (now GN Resound), Director at Coloplast A/S as well as CEO of Danish Health Consult A/S. Additionally, she has been the Dean of the Bioanalyst Faculty in Copenhagen and Mentor at DTU Science Park, DeepTech mentoring since 2014.

Elsebeth privately holds 35,000 warrants in Audientes A/S

Board member since 13/04/2021

Independent of Company

Peter Røpke has an M.Sc. in Electrical, Electronics and Communications Engineering, from Danish Technical University, DTU (1992). He is currently President and CEO for RTX A/S, a Nasdaq Main Market, Mid Cap. company, listed on Nasdaq Nordic, that designs and develops wireless communication products across a wide range of applications. Peter has a long career behind him in product and technology development, manufacturing and consumer electronics. Peter has previously held senior positions at Flügger A/S, Grundfos Management A/S and Nokia Corporation.